foto1 foto2 foto3 foto4 foto5

Our news

  • 18/07/2019: Pharegis implemented optimized procedures for state registration of pharmaceuticals in Eurasian Economic Union.
  • 20/06/2019: Pharegis updated timelines and practical approaches for Russian and EEU GMP inspection applications and procedures.
  • 03/04/2019:  Renewed general monographs of Russian state pharmacopeia XIV ed. have been analyzed.

Global industry news

Feed not found.

Contact us


+7 985 908 58 18

E-mail: |


Regulatory Events Russia

September 2023
27 28 29 30 31 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
October 2023
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31 1 2 3 4

Russian Regulatory News

Pharegis team and career possibilities: registering drugs in Russia, register biosimilars, register generic drugs, conduct clinical studies, bioequivalence studies, pharma regulatory service in Russia by CRO Pharegis expert team

Pharegis team

amalgamates unique combination of different experiences, ways of thinking and life missions under one simple vision: to help business, talking on its language and giving Clear Regulaory Answers.


have many years of managing experience in international western companies in the first place. Our management experience in top 20 international manufacturers as well as top 10 CROs let us present you sophisticated, client-optimized and reliable service in Regulatory Affairs and Clinical trials fields for Russia, Ukraine and CIS countries. Here is structure of our management board:

Pharegis organigram

Experts and consultants

succesfully completed dozens of registration or clinical study projects. All of them had extensive working experience in internationational manufacturers and CROs before joining our team.

And some of our experts have long-track experience in health authorities of Russian Federation, federal expertise and state control institutions.

Together our experts, consultants and managers present well-balanced action team, always getting top quality results, which is one of the most important Value for Pharegis.

Joining us

If you feel that your values resonate with our ones and you have strong experience in the fields of our business, we would be happy to welcome you in our team.

If you want to open new opportunities in your career please send us your CV to: This email address is being protected from spambots. You need JavaScript enabled to view it.


News and press releases

  • Towards a permanent collaboration framework for EMA and Health Technology Assessment bodies, , 15/09/2023
  • EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep, CHMP, 15/09/2023
  • Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023, CHMP, 15/09/2023
  • EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna, CHMP, 15/09/2023